TOP BATTERY

According to foreign media reports, it now appears, in the PC market in 2011 will be a positive direction, business-oriented PC-makers expect from higher sales to get more revenue. 2011 was a year of economic recovery, but also frequent new product and new technology release of the year.

In this year’s MWC Conference, a large number of ARM’s Android-based Tablet PC have emerged, IT players is fair for information and communication (CeBIT) to prepare for this meeting, published in the Light Peak high-speed transmission technology and a way to 300MB flash drive second method the state of work.

According to another report, in 2011, the global PC market will grow, the market will be large numbers of high-end users. In fact, HP, Dell and Lenovo, as the leading supplier of business computers, expects sales this year, a breakthrough. From the fourth quarter of 2010 the situation, business computers, including laptops, the overall sales of 41.28 million units, compared with the fourth quarter of 2009, 38.5 million units There is a jump. HP, which occupies the first name, sold 8.59 million units, quarter grew 8.4% year on year growth of 5.6%. Dell sold 7.08 million units, an increase of 12.9% quarter, down 1.8% year on year. Lenovo sold 6.1 million units, up 20.2% and 7.1%.

Overall, the commercial PC market in 2010 after 7.2% growth, the situation in 2011 will be more optimistic.

Samsung Group said Friday it will work with leading pharmaceutical companies Quintiles (Quintiles Transnational) set up a joint venture to enter the biomedical market. The joint venture plans in the first half of this year’s Ren Chuansong near Seoul City Island, a new pharmaceutical factory, the plant will be under contract to produce drugs using living cells, similar products will include rituximab (Rituxan) of biological agents.

Joint venture investment of 3000 billion won (about 266 million U.S. dollars), of which Samsung Electronics and Samsung Everland (Samsung Everland Inc) each accounted for 40% of the shares, Samsung Corporation (Samsung C & T) and Quintiles 10% each . According to Ministry of Knowledge Economy (Ministry of Knowledge Economy), said in a separate statement, Samsung Group will be responsible for the production of drugs, and Quintiles will be responsible for technology development.

Samsung Group executive vice president Kim Tae Han (Kim Tae Han) that due to huge demand, in 2012, Samsung plans in the field of bio-pharmaceutical revenue of 1.8 trillion won. Korean Mirae Asset Securities (Mirae Asset Securities) analyst Ji Yuan Shen (Shin Ji Won), said in a telephone interview: “bio-pharmaceuticals is a global hotspot, Samsung has repeatedly expressed interest in this area, and the current plan is more practicable. ”

Samsung Group said the joint venture plans to offer the first half of 2013, bio-pharmaceutical products, many of these drugs for the treatment of diseases such as cancer and arthritis, most drugs for export.

IDC said on Wednesday, the Intel chip in the Sandy Bridge problems and will not give AMD the opportunity to gain market share.

IDC research director Xie Enluo (Shane Rau), said competing products, as Sandy Bridge, AMD Llano chip delay has given AMD the opportunity to take the opportunity to gain market share slip away. Llano original plan earlier this year listed, but was delayed because of manufacturing problems to year.

Intel announced in January this year, Sandy Bridge based on the new Core i5 and i7 processors, but Intel’s Sandy Bridge later found design flaws exist, and the suspension of shipments. Until 14 February, Intel announced to fix the problem.

In the meantime, rival AMD to seize the opportunity, on February 18 launched a marketing campaign. But Xieen Luo said such promotions will not give AMD to gain more market share.

Xieen Luo said, AMD is still not compete with Sandy Bridge products. The current AMD and Intel processors only Westmere architecture based on the older generation Core i3, i5, and i7 competition. Xieen Luo said: “AMD will not win much share.”

IDC data show that the fourth quarter of last year, Intel processor market share in the fourth quarter of 2009 from 80.5% to 80.8%, while the share of AMD over the same period from 19.5% to 18.9%. IDC expects the worldwide processor unit shipments will grow 10.1% in 2010 rose 17.1%.